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Abstract
Introduction: The aim of this study is to compare 90-day mortality and morbidity between 
open and laparoscopic surgeries performed in one centre since the introduction of ERAS 
protocols.
Material and Methods: All gastrointestinal surgeries performed between April 2016 and 
March 2019 at our institution after the introduction of ERAS protocols have been ana-
lysed for morbidity and mortality. The analysis was performed in a retrospective manner 
using data from our prospectively maintained database.
* This paper was presented partially at the 31st World Congress of the International Association of 
Surgeons, Gastroenterologists and Oncologists (IASGO 2019) in Bangkok, Thailand.
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Results: We performed 245 gastrointestinal and hepatobiliary surgeries between April 
2016 and March 2019. The mean age of patients was 50.96 years. 135 were open sur-
geries and 110 were laparoscopic surgeries. The mean ASA score was 2.4, the mean 
operative time was 111 minutes and the mean CDC grade of surgery was 2.56. 40 were 
emergency surgeries and 205 were elective surgeries. Overall the 90-day mortality rate 
was 8.5% and the morbidity rate was around 9.79%. On univariate analysis morbidity 
was associated with a higher CDC grade of surgeries, a higher ASA grade, longer op-
erating time, the use of more blood products, a longer hospital stay and open surgeries. 
HPB surgeries and luminal surgeries (non hpb gastrointestinal surgeries) were associ-
ated with 90-day post-operative morbidity. On multivariate analysis no factors indepen-
dently predicted morbidity. On univariate analysis 90-day mortality was predicted by 
the grade of surgeries, a higher ASA grade, longer operative time, the use of more blood 
products, open surgeries and emergency surgeries. However on multivariate analysis 
only the use of more blood products was independently associated with mortality.
Conclusion: The 90-day mortality and morbidity rates between open and laparoscopic 
surgeries after the introduction of ERAS protocol were similar.
Key words: enhanced recovery after surgery (ERAS), laparoscopy, gastrointestinal 
surgery
Introduction
Early recovery after surgery (ERAS) protocol is becoming the gold standard in 
perioperative care with excellent results in colorectal, gastric and HPB surger-
ies [1].
ERAS is an evidence-based perioperative protocol which has shown sig-
nifi cant improvements in perioperative outcomes [2]. Despite this overwhelming 
evidence the implementation of these protocols has been very slow and lacks 
widespread approval [3].
ERAS was initially developed for colorectal surgeries, although it is be-
ing tested in all other fi elds [4]. Unfortunately, it is diffi  cult to have a common 
ERAS protocol across all subspecialties of GI surgery.
In this paper we evaluate perioperative outcomes since the introduction 
of ERAS protocols, which includes upper gastrointestinal, HPB and colorectal 
surgery performed using a laparoscopic or open approach.
Laparoscopic gastrointestinal surgeries have signifi cantly reduced perio-
perative morbidity and mortalities [5]. However, many studies reporting these 
outcomes were conducted before the ERAS era. Very few studies have com-
pared laparoscopic vs open gastrointestinal surgeries since the introduction of 
ERAS protocols.
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Materials and Methods
Since the introduction of ERAS protocols, data for morbidity and mortality from 
all gastrointestinal and HPB surgeries performed between April 2016 and March 
2019 in our institution have been collected prospectively. Morbidity was defi ned 
as any grade of complications according to the Clavien-Dindo classifi cation [6]. 
We also evaluated the factors responsible for morbidity and mortalities as well as 
studies regarding whether there is any diff erence in 90-day morbidity and mortal-
ity between the open or laparoscopic group following ERAS protocol. We per-
form laparoscopic surgery, unless there is a need for conversion, in all benign 
and elective cases, while we perform open surgeries in the case of malignant 
conditions (as we have doubts concerning the oncological outcomes of laparo-
scopic surgeries in the light of recently published trials) and emergency surgeries 
[7]. Ethical approval for our clinical study was obtained from Shalby Hospitals 
Review Board (COA number SBI-5243).
ERAS protocols
We follow the perioperative guidelines for ERAS protocols described for colo-
rectal surgeries in all our gastrointestinal and HPB surgeries [8]. Our ERAS pro-
tocols are explained in table 1.
Table 1. The ERAS protocol as used in the authors’ centre
Preoperative course Nill by mouth not more than 4 hours
Single dose antibiotics at the time of induction
Intra-operative 
and post-operative course
No ryle’s tube post-operatively
No post-operative antibiotics except ongoing sepsis
Early ambulation within 6 hours
Liquid orally within 6 hours, soft diet on post-ope-
rative day 1 and normal diet according to patient’s 
wish from post-operative day 2
No intraoperative drains
Day 1 foley’s catheter removal
Statistical analysis
Statistical analysis was performed using SPSS version 23. A p value less 
than 0.05 was considered statistically signifi cant. The categorial values were 
evaluated using the chi square test, while the numerical values were evalu-
ated using the Mann-Whitney U test. The multivariate analysis was performed 
using the logistic regression method. A Cox multivariate regression analysis 
was performed to evaluate the factors eff ecting 90-day overall and morbidity-
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free survivals. All the factors with a p value of less than 0.05 were included in 
the multivariate analysis.
Results
We performed 245 gastrointestinal and hepatobiliary surgeries between April 
2016 and March 2019. The mean age of patients was 51 years. 144 patients were 
male and 101 were female. 135 were open surgeries and 110 were laparoscopic 
surgeries. 11 were upper gastrointestinal surgeries (stomach and oesophagus), 
27 were small intestinal surgeries, 143 were HPB surgeries, 38 colorectal and 
26 hernia surgeries. The mean ASA score was 2.4, the mean operative time was 
111 minutes, and the mean CDC grade of surgery was 2.56. 40 were emergency 
surgeries and 205 were elective surgeries.
The overall 90-day mortality rate was 8.5% and the overall morbidity 
rate was 9.79%. The 90-day mortality and morbidity in elective surgeries was 
4.08% and 8.16% respectively.
On univariate analysis 90-day morbidity was signifi cant with a higher 
CDC grade of surgeries, a higher ASA grade, longer operative time, the use 
of more blood products and a longer hospital stay. HPB and luminal (stom-
ach, small intestine and large intestine) surgeries were associated with higher 
90-day morbidity (Table 2). On multivariate analysis no factor independently 
predicted morbidity.
On univariate analysis 90-day mortality was predicted by the grade of 
surgeries, a higher ASA grade, longer operative time, the use of more blood 
products, open surgeries and emergency surgeries (Table 3). However, on mul-
tivariate analysis the number of blood products used predicted mortality inde-
pendently (p = 0.046, odds ratio 1.52, 95% C.I. 1.008–2.317).
We also performed a univariate and multivariate analysis of diff erent fac-
tors between the open and laparoscopic groups.
On univariate analysis open surgeries were associated with increased 
morbidity and mortality, although on multivariate analysis open surgery did not 
independently predict morbidity. However, the multivariate analysis showed 
that in the case of open surgeries operative time is signifi cantly increased (Ta-
ble 4).
To confi rm our fi ndings, apart from logistic regression we also performed 
a multivariate Cox regression analysis of 90-day survivals. In this analysis we 
found that a lower operative time, a shorter hospital stay and a smaller number 
of transfused blood products independently predicted a 90-day survival.
We did the same for 90-day morbidity-free survival, which showed that 
no factor independently predicted morbidity-free survival after the Cox regres-
sion multivariate analysis.
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Emergency surgery (n = 40) 4 36 1.0
Luminal Surgery (non HPB gastrointestinal 
surgery)
16 59 <0.0001 0.377
HPB surgery 6 133 0.003 0.573
Age (mean) 51.17 50.94 0.850
Hospital stay (mean) 4.5 2.95 <0.0001 0.421
CDC grade of surgery (mean) 3.04 2.51 <0.0001 0.962
Blood product (mean) 1.42 0.51 <0.0001 0.981
ASA grade (mean) 2.83 2.35 <0.0001 0.691
Operative time (mean) 168.7 104.7 <0.0001 0.142
Table 3. Univariate and multivariate analysis of 90-day mortality
Factors
Mortality









Emergency surgery (n = 21) 11 10 <0.0001 0.116
Open surgery (135) 






Luminal (non HPB) surgeries 11 159 0.087
Morbidity (90-day) 5 19 0.041 0.716
Hospital stay (mean) 3.42 3.08 0.173





ratio 1.52 (95% 
C.I. 1.008–
2.317)
CDC grade of surgery (mean) 3.29 2.5 <0.0001 0.818
Operative time (mean) 177.14 104.79 <0.0001 0.263 
ASA (Mean) 3.1 2.33 <0.0001 0.656
We also prepared 90-day morbidity-free and overall survival-rate curves 
for open and laparoscopic surgeries (Figures 1 and 2), which show that the re-
sults of the Cox multivariate analysis are not statistically signifi cant. 
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Table 4. Multivariate analysis between open and laparoscopic surgeries






Step 1a morbdityall(1) -1.063 1.319 .650 1 .420 .345 .026 4.584
mortality_A(1) -21.629 6941.449 .000 1 .998 .000 .000
LUMINNAL(1) .737 .618 1.425 1 .233 2.090 .623 7.013
EMMERGENCY(1) 2.244 1.118 4.030 1 .045 9.433 1.055 84.371
operativetime -.016 .005 8.739 1 .003 .984 .973 .995
ASA 1.330 .624 4.546 1 .033 3.780 1.113 12.836
hospiitalstay 2.232 .415 28.990 1 .000 9.318 4.135 20.996
gradeofsurgery .941 .544 2.986 1 .084 2.562 .881 7.446
Constant 10.72S 6941.450 .000 1 .999 45479.336
a. Variable(s) entered on step 1: morbdityall, mortality_A, LUMINNAL, EMMERGENCY, operativetime, 
ASA, hospiitalstay, gradeofsurgery. 
Figure 1: 90-day morbidity-free survival between open and laparoscopic 
surgeries, which did not show statistical signifi cance on multivariate 
analysis: p = 0.059, hazard ratio 0.127 95% C.I (0.015–1.079)
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Figure 2: Kaplan meier 90-day survival curve between open and laparoscopic 
surgery, which did not show a signifi cant diff erence in the multivariate 
analysis: p = 0.920
Discussion
Enhanced recovery after surgery, although it was initially described for colorectal 
surgery, is now becoming standard protocol for all surgeries and it has signifi -
cantly reduced hospital stays and costs without aff ecting morbidity and mortality 
[1–5].
However, there are very few studies available that study the eff ect of ERAS 
protocols on morbidity and mortality in the entire cohort including HPB and Gas-
trointestinal surgeries.
We follow ERAS protocols for all gastrointestinal and HPB surgeries, as 
shown in table 1, so we evaluated 90-day morbidity and mortality in our series 
after implementing ERAS protocols and also studied the various factors aff ecting 
90-day morbidity and mortality.
We also evaluated the diff erence in morbidity and mortality in the laparo-
scopic vs open surgery group after implementing the ERAS protocol.
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In our series the overall 90-day mortality rate was 8.5% and the overall 
morbidity rate was around 9.79%. 90-day mortality and morbidity in elective 
surgery were around 4.08 and 8.16% respectively. Mortality is defi ned as any 
death within 90-day post-operative period and morbidity included Clavien-
Dindo grade 3 and grade 4 complications, which is similar to the published data 
[9,10].
In our univariate analysis morbidity was signifi cantly associated with 
a higher CDC grade of surgeries, a higher ASA grade, a longer operative time, 
the use of more blood products, a longer hospital stay and open surgeries. HPB 
surgeries and luminal surgeries (non hpb gastrointestinal surgeries) were asso-
ciated with higher 90-day morbidity. However, in the multivariate analysis no 
factors independently predicted morbidity.
In the univariate analysis 90-day mortality was predicted by the grade of 
surgeries, a higher ASA grade, a longer operative time, greater requirements for 
blood products, open surgeries and emergency surgeries and in the multivariate 
analysis only the greater use of blood products was independently associated 
with higher mortality. These data show that laparoscopic or open surgeries did 
not predicted 90-day morbidity and mortalities independently.
Thus, 90-day morbidity and mortality analysis in our series shows patient 
and disease-related factors, which is also shown in various published studies 
[11–13].
One of the main aims of our study is to evaluate the 90-day morbidity and 
mortality diff erence between open and laparoscopic surgeries after implement-
ing the ERAS protocol.
Various published studies show that morbidity after colorectal resection 
was lower in laparoscopic than in open patients [14,15]. In the case of cholecys-
tectomy it is now concluded that laparoscopic surgery reduces morbidity [16]. 
However, all these papers were published before the widespread introduction 
of the ERAS protocol.
In our study we have analysed laparoscopic and open surgery using uni-
variate and multivariate logistic regression (Table 1) analysis. 90-day morbidity 
and mortality were associated with open surgery in the univariate analysis but 
multivariate logistic regression showed that open or laparoscopic surgeries did 
not independently predict 90-day morbidity and mortality after following the 
ERAS protocol across gastrointestinal and HPB surgeries.
Open surgeries were more complex in terms of longer operative time, the 
higher number of blood products used, the high CDC grade of surgeries, emer-
gency surgeries and high ASA grades as we perform open surgeries as part of 
emergency surgeries and oncologic surgeries, which explains their association 
with morbidity and mortality in univariate analysis. On multivariate analysis 
open surgeries did not predict 90-day morbidity and mortality independently, 
which confi rms that patient-related factors, rather than the open or laparoscopic 
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approaches to surgeries, predict mortality and morbidity following our ERAS 
protocol.
To further confi rm our fi ndings we performed a 90-day survival analysis 
on the multivariate cox regression analysis. However, the hospital stay was 
signifi cantly longer in the open group.
Willem Spanjersberg et al. [17] show that even after implementing 
ERAS, laparoscopic surgeries were associated with reduced morbidity and 
a shorter hospital stay, which is contrary to our data, including all kinds of 
gastrointestinal and HPB surgeries. Cheng-Le Zhuang et al. [18] show that the 
benefi t of laparoscopic surgery in optimal ERAS settings is yet to be proved. 
Rahul Damania et al. [19] show that the ERAS protocol reduced hospital stays 
in the case of HPB surgeries, although they did not compare open vs laparo-
scopic surgeries.
The majority of these data are available for colorectal surgery only. To 
our knowledge ours is one of the fi rst studies to show that if HPB and gastro-
intestinal surgeries are considered together, there is no diff erence in 90-day 
morbidity and mortality between open and laparoscopic surgeries. The hospital 
stay was still signifi cantly longer in the case of open surgery.
Our study suff ers from the bias inherent in all retrospective studies, and 
further randomised control trials are needed to confi rm our fi ndings. Further-
more, although the primary aim of the study is to evaluate the eff ect of the 
ERAS protocol in heterogenous populations, more data for each specifi c sub-
group are needed and we are in the process of evaluating such data.
Conclusion
In conclusion, we have found no diff erence in 90-day morbidity and mortal-
ity between open and laparoscopic surgeries after implementing ERAS pro-
tocols, morbidity and mortality being associated with patient and disease-
related factors.
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Chirurgia klasyczna i laparoskopowa z zastosowaniem schematów ERAS 
wiąże się z podobnym ryzykiem powikłań i zgonów 
Streszczenie 
Wprowadzenie: Celem pracy była ocena ryzyka powikłań i zgonów w ciągu 90 dni po 
zabiegach operacyjnych wykonywanych w jednym z ośrodków sposobem klasycznym 
i laparoskopowym z zastosowaniem schematu zdrowienia pooperacyjnego ERAS.
Materiał i metody: Przeanalizowano wyniki leczenia wszystkich chorych operowanych 
w ośrodku w okresie od kwietnia 2016 r. do marca 2019 r., u których stosowano schemat 
ERAS. Analizę retrospektywną przeprowadzono na danych zbieranych w sposób pro-
spektywny.
Wyniki: Między kwietniem 2016 r. a marcem 2019 r. wykonano 245 zabiegów operacyj-
nych na przewodzie pokarmowym, wątrobie i drogach żółciowych. Średni wiek chorych 
wynosił 50,96 lat. Przeprowadzono 135 operacji sposobem klasycznym oraz 110 metodą 
laparoskopową. Średni wynik w skali ASA wynosił 2,4; średni czas trwania operacji to 
111 minut, a średnia ciężkość operacji w skali CDC – 2,56. 40 zabiegów było wykona-
nych ze wskazań pilnych, a 205 planowych. Całkowity odsetek zgonów pooperacyjnych 
w okresie 90 dni wyniósł 8,5%, a powikłań 9,79%. W analizie jednoczynnikowej czyn-
nikami wpływającymi na ryzyko powikłań były: wyższy wynik w skali CDC, wyższy 
wynik w skali ASA, dłuższy czas trwania operacji, większe zużycie produktów krwiopo-
chodnych, dłuższy czas pobytu w szpitalu, klasyczny dostęp operacyjny, zabiegi w zakre-
sie wątroby i dróg żółciowych. W analizie wieloczynnikowej nie stwierdzono czynników 
wpływających na zwiększenie ryzyka powikłań. W analizie jednoczynnikowej czynnika-
mi wpływającymi na ryzyko zgonów w ciągu 90 dni były: wyższy wynik w skali CDC, 
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wyższy wynik w skali ASA, dłuższy czas trwania operacji, większe zużycie produktów 
krwiopochodnych, klasyczny dostęp operacyjny i zabiegi ze wskazań pilnych. W analizie 
wieloczynnikowej jedynie zużycie preparatów krwiopochodnych wpływało na zwiększe-
nie ryzyka zgonu.
Wniosek: Ryzyko powikłań i zgonów w okresie 90 dni po zabiegach operacyjnych 
z dostępu klasycznego oraz laparoskopowego z zastosowaniem schematu ERAS było 
zbliżone.
Słowa kluczowe: protokół kompleksowej opieki okołooperacyjnej dla poprawy wyników 
leczenia chirurgicznego (ERAS), laparoskopia, chirurgia jamy brzusznej
